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The relationship between benzodiazepines, opioids and tricyclic antidepressants and
trauma is of great importance because of increased consumption and the growing evidence
of a positive association among older adults. The objective of this study was to determine
the effect size of the association between the consumption of psychotropic medications /opi-
oids and falls in patients who have suffered trauma by studying the role of other variables in
this relationship.
Method
From 2011 to 2016, the presence of benzodiazepines, opioids and tricyclic antidepressants
and other drugs in 1060 patients admitted for trauma at a level I trauma hospital was ana-
lysed. Multivariate models were used to measure the adjusted effect size of the association
between consumption of benzodiazepines, opioids and tricyclic antidepressants and falls,
and the effect of age on this association was studied.
Results
A total of 192 patients tested positive for benzodiazepines, opioids and tricyclic antidepres-
sants, with same-level falls being the most frequent mechanism of injury in this group
(40.1%), with an odds ratio of 1.96 (1.40–2.75), p < 0.001. Once other covariates were intro-
duced, this association was not observed, leaving only age, gender (woman) and, to a
lesser extent, sensory conditions as variables associated with falls. Age acted as an effect
modifier between benzodiazepines, opioids and tricyclic antidepressants and falls, with sig-
nificant effect sizes starting at 51.9 years of age.
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(2020) Association of benzodiazepines, opioids and
tricyclic antidepressants use and falls in trauma
patients: Conditional effect of age. PLoS ONE 15
(1): e0227696. https://doi.org/10.1371/journal.
pone.0227696
Editor: Joseph John Westermeyer, University of
Minnesota, UNITED STATES
Received: June 4, 2019
Accepted: December 26, 2019
Published: January 15, 2020
Copyright: © 2020 Cordovilla-Guardia et al. This is
an open access article distributed under the terms
of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: The members of the GISyC group (SCG,
CFA and ESM) are funded by “Programa Operativo
FEDER Extremadura (2014-2020) y Fondo Europeo
Desarrollo Regional (FEDER) Grant number:
GR18146. This work was supported by 4IE+
project (0499_4IE_PLUS_4_E) funded by the
Conclusions
The association between the consumption of benzodiazepines, opioids and tricyclic antide-
pressants and falls in patients admitted for trauma is conditioned by other confounding vari-
ables, with age being the most influential confounding variable.
Introduction
The abusive consumption of substances such as alcohol, cannabis or cocaine poses a substan-
tial morbidity and mortality burden [1]. However, the consumption of benzodiazepines, opi-
oids and tricyclic antidepressants garnering attention because the consumption of these
medications, with or without a prescription, has increased considerably in recent years [2–4].
And although there is a worrying increase in consumption in adolescents [5], the consumption
of these substances is still higher in women and older adults [2,3,6]. The increase in average
life expectancy, social changes such as increased stress, the increased number of unemployed
people, changes in family roles or an over diagnosis and excessive treatment could be a few rea-
sons for this increase [3,4,7–9].
While the short-term therapeutic efficacy of benzodiazepines, opioids and tricyclic antide-
pressants is not in doubt, there are risks associated with their use. In this sense, the association
found between the consumption of benzodiazepines and falls and fractures is especially note-
worthy [10–12], as is its association with increased risk of traffic accidents and injuries [13,14].
Some authors have found that doses of diazepam of 3 mg/day or more increase the risk of hip
fracture by 50%, which increases to 80% if the treatment lasts more than 1 month [11]. The
risk of psychotropic medication-related trauma is aggravated in elderly patients [11], with an
increased risk of falls, osteoporosis and fractures [15–17].
Falls are one of the most important causes of mortality and disability among older people
[16]. In addition, falls lead to numerous hospital admissions, representing almost 90% of all
fractures [16]. One-third of people over 65 experience one or more episodes of falls every year
[17], whose most common sequelae are pain, functional limitations, disability, long-term care
and death, in many cases [18]. Even those falls that do not lead to any injury usually begin a
cycle of fear that leads to limited activities of daily living, occasionally losing independence in
the basic activities of self-care [17].
A high prevalence of traumatic episodes highlights the need to investigate its causes, which
may guide us towards possible intervention strategies [17,19,20]. Although numerous studies
have highlighted the association between the consumption of benzodiazepines, opioids and tri-
cyclic antidepressants and falls/fractures [10,11,20], several variables could be confounding
this relationship. On the one hand, it is known that the abusive use of some psychotropic med-
ications can affect bone density, leading to osteoporosis, fractures and falls [21]. On the other
hand, the consumption of benzodiazepines, opioids and tricyclic antidepressants is linked to
an increase in body mass index (BMI) [16–18]. There is evidence that obesity may play an
important role in falls due to lower levels of physical activity, higher levels of pain or problems
with postural balance [20,21]. In overweight or obese people who suffer a same-level fall, the
impact force is greater; therefore, the consequence of a fall will be proportionally higher [22].
On the other hand, cognitive impairment, even mild, and sensory conditions, such as cata-
racts, significantly increase morbidity in older adults [23]. More than one-third of adults over
65 years of age suffer cataracts annually, causing 1 in 10 falls with serious injuries [18]. Diabe-
tes is another influential factor in episodes of trauma, especially in falls. Thus, adults with type
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2 diabetes mellitus have an increased risk of falls [17]; however, the factors that determine this
relationship are not yet known. We can also find evidence that problems related to blood pres-
sure could lead to falls [18,23].
In short, although the literature has highlighted the relationship between the consumption
of psychotropic medications and trauma, there is a lack of evidence on the impact that the con-
sequences of the consumption of benzodiazepines, opioids and tricyclic antidepressants (oste-
oporosis, increased BMI) or other variables independent of the consumption of psychotropic
medications (age, gender, cognitive decline, sensory conditions, diabetes, hypertension) may
have on this relationship. Additionally, studies that have explored the prevalence of the con-
sumption of benzodiazepines, opioids and tricyclic antidepressants and other substances in
trauma patients find a high percentage of falls associated with people who consume these sub-
stances [24,25] but do not determine the effect size of the association between these factors or
the role that other variables could play in the association. Therefore, the objective of the pres-
ent study was to determine, in patients who have suffered trauma, the effect size of the associa-
tion between psychotropic medication consumption and falls by studying the weights that the
mediating and confounding variables may have in this association.
Methodology
A cross-sectional analytical study was based on data obtained from a secondary prevention
SBIRT-based program for traumatized patients associated with alcohol and/or other drugs at
the Trauma Hospital of Granada. The research was approved by the Granada Provincial
Research Ethics Committee (CEI-Granada) and conducted according to the principles
expressed in the Declaration of Helsinki; including informed consent obtained from the par-
ticipants or their relatives or guardians in minor participants.
The population for this study was 1060 patients admitted for trauma in the aforementioned
hospital, in the periods in which the programme was active, comprising 34 non-consecutive
months during which it received public financial support: from November 2011 to October
2012, June 2013 to November 2013 and June 2014 to February 2015.
Study variables
The presence of benzodiazepines and analogues (zopiclone, zolpidem and zaleplon), prescrip-
tion opioids, tricyclic antidepressants and drugs of abuse (cannabis, cocaine, amphetamines,
methamphetamines, heroin, and methadone) was detected by urinalysis via fluorescence
immunoassay (LifeSign StatusFirst 1). Review of the patient’s medical records and direct
questioning were used to distinguish between patients who screened positive for positive
results for benzodiazepines and opioids as a result of emergency treatment of their injuries
and patients who had taken these substances before they sought medical attention. Alcohol
was considered positive if the blood alcohol level exceeded 0.3 g/L on admission or if, given
the narrow detection window, the patient self-reported alcohol consumption.
Age, gender, presence of a diagnosed psychiatric disorder, mechanism of injury (traffic
accident, sports accident, aggression, same-level falls or falls from a height, blows-cuts and
other mechanisms), severity of the trauma measured by the injury severity score (ISS) [26],
hospital mortality, and variables of exposure to the aforementioned substances were collected
prospectively during the implementation of the secondary prevention protocol project. Cogni-
tive impairment prior to trauma; diagnoses of diabetes, osteoporosis, hypertension, heart dis-
ease, and obesity; and/or impaired balance, musculoskeletal conditions or sensory system
conditions were collected retrospectively during the months of January to May 2016 for this
study, using the Medical History of the Andalusian Health System Diraya 1 [27]
Psychotropic medications use and falls: Conditional effect of age
PLOS ONE | https://doi.org/10.1371/journal.pone.0227696 January 15, 2020 3 / 12
Data analysis
For the data analysis, the presence of benzodiazepines, opioids and tricyclic antidepressants
was dichotomized as positive or negative. Trauma severity was classified according to the ISS
as mild (1–8), moderate (9–15) or severe (�16). As a dependent variable, the mechanism of
injury was used, categorized into 2 strata: same-level falls versus other mechanisms.
For the descriptive study, after verifying the lack of normality in the distribution of the con-
tinuous variables, the distribution of these variables was compared using the Mann-Whitney U
test. To examine the association of categorical variables, the Pearson Chi-squared test was used.
For the analytical analysis, the strength of the association between the consumption of ben-
zodiazepines, opioids and tricyclic antidepressants and falls was quantified by applying a binary
logistic regression model where negative outcomes for psychopharmaceuticals and other non-
fall injury mechanisms were considered as reference categories. This allowed obtaining crude
odds ratios (ORc) and adjusted odds ratios (ORa). For ORa, the independent variables psychiat-
ric disorder, cognitive decline, hypertension, osteoporosis, diabetes, impaired balance, musculo-
skeletal conditions, heart disease, sensory conditions, obesity, alcohol consumption, cannabis
consumption, cocaine consumption, amphetamine consumption and methadone consumption
were added to the model. In addition, exploratory analyses were performed to determine which
factors acted as effect modifiers. These analyses were developed according to the method of
Hayes and colleagues [28,29] through the macro PROCESS in SPSS [29]. This method allowed
us to measure the conditional effect of the association between the use of benzodiazepines, opi-
oids and tricyclic antidepressants and falls with which Fig 1 has been carried out. All analyses
were performed using SPSS 24.0 for Windows (SPSS, Chicago, IL). The confidence interval was
established at 95% (CI 95%), considering values of p� 0.05 significant.
Results
Descriptive study
In the comparison of the demographic and clinical characteristics between the groups con-
suming or not consuming benzodiazepines, opioids and tricyclic antidepressants (Table 1),
age was higher in the group of patients consuming benzodiazepines, opioids and tricyclic anti-
depressants, with a median (interquartile range) of 48 years (39.25–59) versus an age of 42
years (28–53) for patients negative for benzodiazepines, opioids and tricyclic antidepressants.
With regard to gender, equality between male and female consumers of benzodiazepines, opi-
oids and tricyclic antidepressants was notable (96 patients, 50%). In the group of patients nega-
tive for benzodiazepines, opioids and tricyclic antidepressants, male gender represented 74.1%
(643 patients), with female gender representing 25.9% (225 patients). Previous diagnosis of a
psychiatric disorder was lower in the group of patients negative for benzodiazepines, opioids
and tricyclic antidepressants (1.4%, 12 patients) than in the group positive for these substances
(39.1%, 75 patients).
We also found differences in the distribution of the mechanism of injury, with a much higher
percentage of falls in the group of psychopharmaceutical consumers compared to non-consumers
(40.1% vs. 28.2%, p< 0.001). Regarding the other variables, we did not find differences in trauma
severity; however, there was a higher percentage of osteoporosis in the group positive for benzodi-
azepines, opioids and tricyclic antidepressants (4.7% versus 1.6% in the non-consumer group).
Regarding musculoskeletal deficiency, 3.1% (6 patients) of those who consumed psychopharma-
ceuticals had some deficiency, compared to 0.8% (7 patients) of non-consumers. Regarding sen-
sory conditions, 3.1% (6 patients) of those who consumed psychopharmaceuticals had some type
of condition, compared to 2.6% (23 patients) of non-consumers.
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Regarding the consumption of other drugs, significant differences were found, with an
increased consumption of other substances (cannabis, cocaine, amphetamines and metha-
done) in the group positive for psychotropic medicines.
Analytical study
Table 2 shows estimates of crude and adjusted ORs to quantify the effect size of the association
of each variable with same-level falls. If we examine the analysis of the crude association, i.e.,
of all the variables independently with same-level falls, there is a significant association in
almost all, except cognitive decline and methadone consumption. The consumption of
Fig 1. Conditional effect of age in the association between the use of benzodiazepines, opioids and tricyclic antidepressants and falls.
https://doi.org/10.1371/journal.pone.0227696.g001
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benzodiazepines, opioids and tricyclic antidepressants was associated with an ORc (95% CI) of
1.96 (1.40–2.75), p< 0.001. However, when all variables are introduced into the multivariate
analysis, this association is not observed, leaving only a significant relationship of age and gen-
der with falls, with an ORa (95% CI) of 1.04 (1.03–1.05), p< 0.001, and 3.00 (2.16–4.17),
p< 0.001, respectively. In addition, the relationship between trauma and sensory conditions
was also maintained; however, it loses strength, and the consumption of cannabis appears to
be a protective factor against sensory condition symptoms.
Table 1. Baseline characteristics of the groups.
Non-users of benzodiazepines, opioids and tricyclic
antidepressants (n = 868)
Users of benzodiazepines, opioids and tricyclic
antidepressants (n = 192)
p value
Age (years) Median (IQR) 42 (28–53) 48 (39.25–59) <0.001
Sex n (%)
Male 643 (74.1) 96 (50) <0.001
Psychiatric Disorder n (%) 12 (1.4) 75 (39.1) <0.001
Mechanism of injury n (%)
Traffic collision 253 (29.1) 30 (15.6)
Sports injury 80 (9.2) 6 (3.1)
Assault 46 (5.3) 12 (6.2)
Falls on the same level 245 (28.2) 77 (40.1) <0.001
Falls from a height 105 (12.1) 35 (18.2)
Cuts or bruises 97 (11.2) 12 (6.2)
Other mechanisms 42 (4.8) 20 (10.4)
Injury Severity Score n (%)
Mild: 1 to 8 605 (69.7) 130 (67.7)
Moderate: 9 to 15 156 (18) 38 (19.8) 0.828
Severe:�16 107 (12.3) 24 (12.5)
Death n (%) 18 (2.1) 2(1) 0.342
Cognitive Impairment n
(%)
6(0.7) 4 (2.1) 0.154
Diabetes n (%) 66 (7.6) 16 (8.3) 0.743
Osteoporosis n (%) 14 (1.6) 9 (4.7) 0.028
HBP n (%) 111(12.8) 35 (18.2) 0.108
Alterations of Balance n
(%)
5(0.6) 0 (0.0) 0.455
Locomotor system diseases
n (%)
7(0.8) 6 (3.1) 0.024
Heart Disease n (%) 37 (4.3) 9 (4.7) 0.762
Sensorial Alterations n (%) 23 (2.6) 6 (3.1) 0.024
Obesity n (%) 22 (2.5) 9 (4.7) 0.258
Other substance detected n
(%)
Alcohol 196(22.6) 54 (28.1) 0.102
Cannabis 104 (12) 34 (17.7) 0.033
Cocaine 40(4.6) 20 (10.4) 0.002
Anphetamine 1(0.1) 8 (4.2) <0.001
methadone 0 (0.0) 23 (12) <0.001
IQR: Interquartile range. HBP: High blood pressure. Benzodiazepines, opioids and tricyclic antidepressants: benzodiazepines and analogues, tricyclic antidepressants,
opiate derivatives (excluding heroin and methadone).
https://doi.org/10.1371/journal.pone.0227696.t001
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In the mediation/moderation analyses, we found that the non-standardized direct effect
size of psychotropic medication consumption with falls was β: 0.73 (95% CI: -0.28; 9.09),
p = 0.066. However, age exerted a significant interaction on the effect of psychotropic medica-
tion consumption on falls (p = 0.025), with conditioned effect values that increased with age,
with significant values starting at 51.9 years (Fig 1).
Discussion
When determining the relationship between the consumption of benzodiazepines, opioids and
tricyclic antidepressants and falls, assessing the impact of other variables in this association,
our main finding is that although the crude association shows a clear relationship between
most variables that, a priori, could be linked to this mechanism of injury, this association is not
observed after introducing all these factors in a multivariate model. Only the variables age,
gender, and sensory conditions remain significantly associated, and negatively so with canna-
bis consumption. The study of mediation/moderation showed that of these variables, age mod-
ified the effect of benzodiazepines, opioids and tricyclic antidepressants in falls, becoming
significant after 51.9 years of age. These results suggest that the consumption of benzodiaze-
pines, opioids and tricyclic antidepressants is not directly related to a greater number of falls
compared to other mechanisms of injury in trauma patients, as noted by some studies [24],
but the effect of the association of the consumption of these substances with the falls is progres-
sively conditioned by age; with a significant conditional effect from 51.9 years. On the other
hand, falls appear associated with female gender and, to a lesser extent, sensory conditions
(blindness, deafness, etc.). The emergence in our study of cannabis as an inversely associated
Table 2. Multivariate analysis�. Association between study variables and falls.
cOR (95%CI) p aOR (95%CI) p
Age 1.06 (1.05–1.07) <0.001 1.04 (1.03–1.05) <0.001
Sex (Male Reference) 4.26 (2.21–5.47) <0.001 3.00 (2.16–4.17) <0.001
Cognitive Impairment 1.53 (0.43–5.48) 0.509 0.78 (0.19–3.21) 0.734
Diabetes 2.23 (1.41–3.51) 0.001 0.91 (0.52–1.57) 0.724
Osteoporosis 8.68 (3.19–23.6) <0.001 1.76 (0.60–5.14) 0.300
HBP 3.37 (2.35–4.81) <0.001 1.52 (0.97–2.39) 0.069
Alterations of Balance 9.27 (1.03–83.3) 0.047 6.22 (0.56–68.7) 0.136
Locomotor system diseases 5.28 (1.61–17.3) 0.006 2.43 (0.66–8.91) 0.179
Heart Disease 1.99 (1.10–3.61) 0.024 0.72 (0.34–1.51) 0.385
Sensorial Alterations 4.57 (2.10–9.93) <0.001 2.54 (1.03–6.28) 0.043
Obesity 2.20 (1.08–4.52) 0.031 0.85 (0.38–1.90) 0.693
Psychiatric Disorder 1.79 (1.14–2.79) 0.011 0.92 (0.48–1.77) 0.810
Epilepsy 1.28 (0.42–3.84) 0.663 1.27 (0.35–4.62) 0.716
Alcohol detected 0.56 (0.40–0.78) 0.001 0.92 (0.62–1.35) 0.662
Cannabis detected 0.15 (0.08–0.29) <0.001 0.45 (0.22–0.92) 0.028
Cocaine detected 0.11 (0.03–0.36) <0.001 0.38 (0.11–1.31) 0.125
Methadone detected 0.34 (0.10–1.14) 0.081 0.64 (0.08–5.50) 0.687
Heroine detected 0.36 (0.14–0.93) 0.036 1.21 (0.22–6.68) 0.824
Benzodiazepines, opioids and tricyclic antidepressants detected 1.96 (1.40–2.75) <0.001 1.11 (0.67–1.86) 0.679
� By binary logistic regression; mechanism of injury other than falls as a reference. 95%CI: 95% confidence interval. Benzodiazepines, opioids and tricyclic
antidepressants: benzodiazepines and analogues, tricyclic antidepressants, opiate derivatives (excluding heroin and methadone). Significant P values (< 0.05) are in
bold.
https://doi.org/10.1371/journal.pone.0227696.t002
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factor with the consumption of falls could be due to the known strong link existing in the con-
sumption of this substance with other mechanisms, such as traffic accidents [30].
Numerous studies have confirmed the association between psychotropic medication use
and falls in elderly people [15,16,31–33]. Pratt et al 2014 [15] found an increased numbers or
increased doses of psychoactive medicines are associated with an increased risk of hospitaliza-
tion for falls in older adults with adjusted models by age and sex. However, important method-
ological differences prevent us from comparing our results: First, the study by Pratt et al 2014
was carried out only with a population over 65 years of age; by decreasing the detection spec-
trum by age it is more difficult to determine its influence on the association. In addition,
although the study has a considerable sample size, due the use of records to determine the
exposure, it is possible that some patients who were classified as being exposed only took the
medicine for a few days or did not consume the medicine, similarly, patients who took the
drug without a prescription could be mistakenly classified as non-consumers. To the best of
our knowledge, no previous study has investigated the possible influence of mediating and
confounding variables in the relationship between psychotropic medication consumption and
falls in trauma patients by prospective systematic screening of exposure to these substances.
Therefore, we believe that this study provides a novel point of view for understanding the fac-
tors that are related to trauma incidents and their characteristics.
Our descriptive study shows that the age of consumers of benzodiazepines, opioids and tri-
cyclic antidepressants that have suffered trauma, average of 48 years of age, is clearly higher
than that of the rest of the patients, a finding that coincides with those of the Spanish Monitor-
ing Centre for Drugs and Drug Addiction (Observatorio Español de la Droga y las Toxicoma-
nı́as) and other studies that place the age of onset of the use of these substances at 45 years of
age, much higher than that of other substances of abuse [9,34,35]. For gender, although trau-
matic pathology is strongly linked to male gender [36], the percentage of women who con-
sumed psychopharmaceuticals in our study was similar to that of men, a reflection of the
strong association that exists between the consumption of these substances and the female gen-
der in the general population [9,19].
In line with the findings of the Report on Drug Use in Spain, published in 2015 [34], our
data also indicate that alcohol is the most frequently consumed substance. In fact, alcohol con-
sumption in Spain is considered universal because more than 93% of people aged 15 to 64 con-
sume alcoholic beverages on occasion [34], and the association between consumption and
trauma is widely known [37]. Surprisingly, benzodiazepines were the second most common
substance found after cannabis, which supports the increasing trend in our country of the con-
sumption of these drugs, with or without a prescription [38], observing a growing trend since
2005 in the consumption of hypnosedatives; however, the perceived risk has not increased
[34]. This fact, coupled with increasing evidence indicating an increased risk of trauma associ-
ated with these substances [13], should provide a warning for our country, especially for older
individuals who consume these substances because falls are a frequent problem in people over
65 years of age, and the consumption of these medications is directly related to an increased
risk of falls [39]. Some studies report a decrease in falls by up to 66% through minimizing pre-
scriptions for these substances [40].
Notably, in our sample, there was a significantly higher number of drugs other than alcohol
in psychotropic medication users. The use of central nervous system depressants to reduce the
effect of stimulants such as cocaine and methamphetamine has also been found in previous
studies [41].
The main limitations of this study include the impossibility of extrapolating the results to
patients who suffer trauma and are not hospitalized. Furthermore, the retrospective collection
of some of the variables used in the study, through a review of patient medical records, could
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lead to underestimations of some pathologies, such as those that are still latent and have not
been diagnosed, for example, obesity, whose detection sensitivity through this method is ques-
tionable. On the other hand, patients who were admitted with blood alcohol levels of 0.3 g/L or
lower have not been considered positive for alcohol. This is because it is the legal limit allowed
in our country for novice and professional drivers. However, the concentration of alcohol in
the blood related to an increased risk of trauma in the elderly may not coincide with that
legally established for driving due to the special susceptibility of this age group [42].
Despite these limitations, this study presents important strengths. It is noteworthy that this
study was carried out within a project in which a systematic screening of substances in patients
admitted for trauma was carried out. In this study, positive tests for benzodiazepines and opi-
oids were prospectively excluded when these drugs were administered as part of the prehospi-
tal or emergency treatment, thus avoiding false positives. Although there may be some cases
that the use of benzodiazepines in prehospital care for serious trauma could have masked the
previous consumption of non-prescribed benzodiazepines (if the patient had medical records
of prescribed benzodiazepines was screened as positive), we believe that our approach is more
adequate than systematically discarding these benzodiazepine positive screenings. On the
other hand, the design of the present study allowed us to avoid selection biases present in
other studies in which consumption was detected by means of questionnaires [43] or through
prescription databases [10]. However, the method employed cannot guarantee the total
absence of other potential biases, such as those that could occur due, for example, to trauma
associated with drug withdrawal (in which levels may be non-existent or quite low), to exclu-
sion of cases positive for opioids and benzodiazepines (without further efforts to identify pre-
trauma use of these commonly used and abused substances), and to episodic or binge use of
psychotropic substances can that can produce brain and heart lesions that can precipitate falls
and other forms of trauma (especially opioids used with or without benzodiazepines) in the
absence of current psychotropic use.
In conclusion, we can affirm that despite the crude data suggesting a relationship between
the consumption of benzodiazepines, opioids and tricyclic antidepressants and falls in patients
who have suffered trauma, this relationship is influenced by other variables that confound or
modify the effect of this relationship. However, the conditional effect that age exerts on this
association only begins to be significant after 51.9 years of age. The influence of benzodiaze-
pines, opioids and tricyclic antidepressants on trauma risk cannot be called into question
given the methodology and population used in this study; however, future research conducted
in this regard should account for the importance of non-causal associations that could be gen-
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Methodology: Sergio Cordovilla-Guardia, Cristina Franco-Antonio, Raquel Vilar-López.
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F, Franco-Antonio C, et al. Association between the detection of alcohol, illicit drugs and/or psychotropic
medications/opioids in patients admitted due to trauma and trauma recidivism: A cohort study. Gabbe
BJ, editor. PLoS One. Public Library of Science; 2018; 13: e0203963. https://doi.org/10.1371/journal.
pone.0203963 PMID: 30208111
26. Copes WS, Champion HR, Sacco WJ, Lawnick MM, Keast SL, Bain LW. The Injury Severity Score
revisited. J Trauma. 1988; 28: 69–77. https://doi.org/10.1097/00005373-198801000-00010 PMID:
3123707
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